Monday, February 18, 2013

New study fuels debate over the value of copay offset cards

A new study is adding fuel to the debate over the value of copay offset cards, used to defer a patient’s copayment for prescription medications.

Released in December by New Jersey-based Alliance Life Sciences Consulting Group, the study looks at the attitudes of patients, pharmacists, physicians and payers toward prescription copay offset cards.

(See my complete column on the topic in Healthcare Finance News)

No comments:

Post a Comment